Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Journal of Translational Medicine

Figure 3

From: Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients

Figure 3

Anti-MMP11 detection in plasma samples. MMP11 antibodies were measured by ELISA. Anti-MMP11 titers were calculated as the reciprocal limiting dilution of plasma producing an absorbance at least 3-fold greater than the absorbance of control samples average at the same dilution. The assay was run in duplicate and repeated twice. A threshold at 1:200 was arbitrarily set to identify seropositive patients. BR, breast; PROST, prostate; C, controls.

Back to article page